This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gryglewski, R. J. Articles by Vane, J. R. Search for Related Content PubMed PubMed Citation Articles by Gryglewski, R. J. Articles by Vane, J. R.

Hypertension, Vol 12, 530-548, Copyright © 1988 by American Heart Association

ARTICLES

Mediators produced by the endothelial cell

RJ Gryglewski, RM Botting and JR Vane
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, UK.

This review discusses the role of three mediators, synthesized by vascular endothelial cells, that help to keep the surface of the normal endothelium nonthrombogenic. The first is prostacyclin, a product of arachidonic acid metabolism discovered in 1976. This labile prostanoid, with a half-life of approximately 3 minutes, relaxes vascular smooth muscle and inhibits the aggregation of blood platelets. Prostacyclin and its analogues are currently being tested clinically for use in cardiovascular diseases such as primary pulmonary hypertension. The second mediator discussed is endothelium-derived relaxing factor (EDRF), discovered in 1980, which also relaxes smooth muscle and inhibits the aggregation and adhesion of platelets. Substances that stimulate the release of EDRF include acetylcholine, bradykinin, and adenosine 5'-diphosphate. EDRF is even more labile than prostacyclin, with a half-life of about 6 seconds, and it has recently been identified as nitric oxide. Prostacyclin and EDRF are released together following stimulation of endothelial receptors and synergize to inhibit platelet aggregation. 13-Hydroxy-9,11-octadecadienoic acid, a third suggested mediator, is not released but acts from inside the cell to make the endothelial surface nonadhesive for circulating blood cells. It is proposed that these three mediators form the endothelial defense mechanism against blood-borne cells and chemicals and that breakdown of this barrier results in diseases such as hypertension and atherosclerosis.

This article has been cited by other articles:

				M. Herrera and J. L. Garvin Novel role of AQP-1 in NO-dependent vasorelaxation Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1443 - F1451. [Abstract] [Full Text] [PDF]

				K. M. Fetalvero, M. Shyu, A. P. Nomikos, Y.-F. Chiu, R. J. Wagner, R. J. Powell, J. Hwa, and K. A. Martin The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1337 - H1346. [Abstract] [Full Text] [PDF]

				V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF]

				J. T. Butcher, A. M. Penrod, A. J. Garcia, and R. M. Nerem Unique Morphology and Focal Adhesion Development of Valvular Endothelial Cells in Static and Fluid Flow Environments Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1429 - 1434. [Abstract] [Full Text] [PDF]

				A. I. Vinik, T. Erbas, T. S. Park, R. Nolan, and G. L. Pittenger Platelet Dysfunction in Type 2 Diabetes Diabetes Care, August 1, 2001; 24(8): 1476 - 1485. [Abstract] [Full Text] [PDF]

				Z. Tahawi, N. Orolinova, I. G. Joshua, M. Bader, and E. C. Fletcher Physiological and Genomic Consequences of Intermittent Hypoxia: Selected Contribution: Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats J Appl Physiol, May 1, 2001; 90(5): 2007 - 2013. [Abstract] [Full Text] [PDF]

				E. C. Fletcher Physiological and Genomic Consequences of Intermittent Hypoxia: Invited Review: Physiological consequences of intermittent hypoxia: systemic blood pressure J Appl Physiol, April 1, 2001; 90(4): 1600 - 1605. [Abstract] [Full Text] [PDF]

				H. Yamawaki, K. Sato, M. Hori, H. Ozaki, S.-I. Nakamura, H. Nakayama, K. Doi, and H. Karaki Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H318 - H323. [Abstract] [Full Text] [PDF]

				L. A. Gumprecht, V. R. Beasley, R. M. Weigel, H. M. Parker, M. E. Tumbleson, C. W. Bacon, F. I. Meredith, and W. M. Haschek Development of Fumonisin-Induced Hepatotoxicity and Pulmonary Edema in Orally Dosed Swine: Morphological and Biochemical Alterations Toxicol Pathol, November 1, 1998; 26(6): 777 - 788. [Abstract] [PDF]

				M. Camacho, J. Lopez-Belmonte, and L. Vila Rate of Vasoconstrictor Prostanoids Released by Endothelial Cells Depends on Cyclooxygenase-2 Expression and Prostaglandin I Synthase Activity Circ. Res., August 24, 1998; 83(4): 353 - 365. [Abstract] [Full Text] [PDF]

				S. T. Davidge and Y. Zhang Estrogen Replacement Suppresses a Prostaglandin H Synthase–Dependent Vasoconstrictor in Rat Mesenteric Arteries Circ. Res., August 24, 1998; 83(4): 388 - 395. [Abstract] [Full Text] [PDF]

				M. Booke, R. Waurick, H. Van Aken, H.-G. Bone, Andreas Meissner, T. Prien, and J. Meyer Effects of sympathetic nerve blockade on vasoconstrictive properties of nitric oxide synthase inhibition in sheep Cardiovasc Res, October 1, 1997; 36(1): 111 - 117. [Abstract] [Full Text] [PDF]

				F B. Pipkin Fortnightly Review: The hypertensive disorders of pregnancy BMJ, September 2, 1995; 311(7005): 609 - 613. [Abstract] [Full Text]

				T. A. Bruning, P. C. Chang, M. G.C. Hendriks, P. Vermeij, M. Pfaffendorf, and P. A. van Zwieten In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential Hypertension Hypertension, July 1, 1995; 26(1): 70 - 77. [Abstract] [Full Text]

				M. J.A.P. Daemen and J. G.R. De Mey Regional Heterogeneity of Arterial Structural Changes Hypertension, April 1, 1995; 25(4): 464 - 473. [Abstract] [Full Text]

				D. H. Sigmon and W. H. Beierwaltes Endothelium-Derived Constricting Factor in Renovascular Hypertension Hypertension, April 1, 1995; 25(4): 803 - 808. [Abstract] [Full Text]

				T. J. Spyt, K. L. Blake, P. A. C. Watt, and H. Thurston Inhibition of Endothelium-Dependent Relaxation by Free Hemoglobin in the Human Internal Thoracic Artery Vascular and Endovascular Surgery, January 1, 1994; 28(1): 1 - 6. [Abstract] [PDF]

				M. Cybulsky and M. Gimbrone Jr Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science, February 15, 1991; 251(4995): 788 - 791. [Abstract] [PDF]